Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Hybrid MOPP/ABVD and radiotherapy in advanced Hodgkin's disease.
Salvagno L, Sorarù M, Sotti G, Aversa S, Chiarion Sileni V, Mazzarotto R, Scarzello G, Bianco A, Pappagallo GL, Fiorentino MV. Salvagno L, et al. Among authors: soraru m. Ann Oncol. 1995 Feb;6(2):173-9. doi: 10.1093/oxfordjournals.annonc.a059113. Ann Oncol. 1995. PMID: 7540419 Free article.
Secondary leukemia following treatment for Hodgkin's disease.
Salvagno L, Simonato L, Sorarù M, Bianco A, Chiarion-Sileni V, Aversa SM, Camporese R, Garofolin P, Fiorentino M. Salvagno L, et al. Among authors: soraru m. Tumori. 1993 Apr 30;79(2):103-7. doi: 10.1177/030089169307900204. Tumori. 1993. PMID: 8346559
Safety and efficacy of nivolumab for metastatic renal cell carcinoma: real-world results from an expanded access programme.
De Giorgi U, Cartenì G, Giannarelli D, Basso U, Galli L, Cortesi E, Caserta C, Pignata S, Sabbatini R, Bearz A, Buti S, Lo Re G, Berruti A, Bracarda S, Cognetti F, Rastelli F, Fornarini G, Porta C, Turci D, Sternberg CN, Procopio G; Italian Nivolumab Renal Cell Cancer Early Access Program Group. De Giorgi U, et al. BJU Int. 2019 Jan;123(1):98-105. doi: 10.1111/bju.14461. Epub 2018 Jul 23. BJU Int. 2019. PMID: 29956884 Free article.
37 results